A group of Republicans in the House of Representatives are joining together to introduce two bills that would reverse the Food and Drug Administration’s (FDA) rule permitting women to access the abortion pill via telemedicine and through the mail. Companion bills will also be introduced in the U.S. Senate.
The House bill, the “Protecting Life from Chemical Abortions Act,” along with the Senate bill, the “SAVE Moms and Babies Act of 2023,” would stipulate that women can only access the abortion pill in person – which until 2020, had been the FDA’s policy for two decades.
Additionally, the bills would:
- Prevent the executive branch from declaring an abortion-related public health emergency.
- Stop the FDA from waiving the “in person dispensing requirement” for the abortion pill and other safety regulations for chemical abortion drugs.
Another House bill, the “Nullifying President Biden FDA’s Abortion Pill Final Rule,” would reverse the FDA’s January 3, 2023, decision making the abortion pill more widely available.
On January 3, the FDA changed its “Mifepristone REMS Program” to make the first drug of the abortion pill easier to obtain, permitting retail pharmacies like CVS and Walgreens to dispense the pill. Previously, the FDA only allowed the abortion pills to be dispensed by clinics, medical offices and hospitals.
And on December 23, 2022, the U.S. Department of Justice (DOJ) issued a legal opinion stating that one section of federal law which declares that “every article or thing designed, adapted, or intended for producing abortion” does not apply to Mifepristone. This opinion to the U.S. Postal Service (USPS) gives the USPS a green light to distribute the dangerous abortion drugs through the mail.
Senator James Lankford is leading a letter to Attorney General Merrick Garland, asking him to rescind the DOJ’s opinion. Sen. Lankford’s letter argues that the memo disregards the plain meaning of the law and misapplies circuit court precedents related to the mailing of contraceptives.
The abortion pill is a two-pill regimen. The first drug, Mifepristone, blocks the pregnancy hormone progesterone, which is necessary for a preborn baby to develop. This drug is authorized by the FDA for use in the first 10 weeks of pregnancy.
The second drug, Misoprostol, is taken one to two days after Mifepristone. The drug causes contractions to expel the baby from the mother’s womb.
Over half of all abortions – 54% – are now done via the abortion pill. However, considering yearly trends and the FDA’s recent actions, the number of abortions performed via the abortion pill is likely to continue to increase.
Rep. Diana Harshbarger, R-Tenn., along with 13 other members of the Republican Study Committee introduced the bill to reverse the FDA’s rule change. She told the Daily Signal that the FDA’s rule change was just the latest example of the administration’s “crusade toward abortion on demand at any cost, even at the expense of women’s health.”
“Every woman in American deserves to know the heightened risks involved with chemical abortions before they make a life-altering decision,” Rep. Harshbarger added. “My bill restores commonsense and proper safety prescriber requirements for the dispensing of these dangerous abortion drugs.”
Ironically, 96-year-old Dr. Étienne-Émile Baulieu who created the abortion pill, originally thought that it might “even help eliminate abortion as an issue.” Obviously, he was dead wrong. Dr. Baulieu who has touted his invention, saying, “When science meets women’s cause, it is irresistible,” has had multiple affairs; His invention hasn’t helped women either.
As the Daily Citizen has previously reported, the abortion pill is anything but safe. The FDA’s “REMS” designation, or Risk Evaluation and Mitigation Strategy, was placed on Mifepristone because there are “serious safety concerns” about the medication. Possible side effects include hemorrhage, infection, fever, vomiting, weakness, headache, pulmonary embolism, deep vein thrombosis, infertility, depression and death.
Since it is so dangerous, the FDA has long required Mifepristone to be prescribed by a licensed physician in a clinical setting.
All that changed in 2020, when ostensibly due to COVID-19, far leftist activist legal groups sued the FDA to force the agency to permit the abortion pill to be accessed via telemedicine and through the mail.
The FDA announced in December 2021 that it was permanently doing away with the “in-person dispensing requirement.”
However, the U.S. Congress is renewing the fight for life.
Just last week, the House passed several pieces of pro-life legislation, including a resolution condemning attacks on pro-life entities like pregnancy resource centers, and the Born-Alive Abortion Survivors Protection Act.
Let’s hope the House will soon pass these commonsense bills to reverse the FDA’s recent rule change and protect women, and that the Senate will eventually follow suit.
Some women, after taking the first abortion pill (Mifepristone) come to regret their decision. Thankfully, there is a way to reverse the pill’s effects if prompt action is taken.
To learn more about the abortion pill reversal protocol, visit abortionpillreversal.com or call 1-877-558-0333 to be connected with a medical professional who can guide callers through the process of reversing the pill’s effects.
Additionally, if you need help, Focus on the Family offers a free, one-time counseling consultation with a licensed or pastoral counselor. To request a counseling consultation, call 1-855-771-HELP (4357) or fill out our Counseling Consultation Request Form.
Related articles and resources:
Photo from Shutterstock.